×banner icon

Spirometry and Feno, Important diagnostic and monitoring tools for the Asthmatic patient.

177 avis
Vyaire Medical

Vyaire Medical

Voir plus
  • Pneumologie, Thérapeute Respiratoire
  • 1 jour de formation   /   Durée effective : 1h
  • 500 participants par session
  • Anglais

Détails de la formation

There is increasing evidence that asthma is a heterogeneous pathological condition characterized by different phenotypes/endotypes related to specific pathological pathways. Exhaled nitric oxide (FeNO), is a biomarker of one pathologic pathway, allergic airway inflammation, that has proven helpful to predict therapeutic response in selected asthmatic populations. FeNO is a quantitative, non-invasive, simple and safe method of measuring allergic airway inflammation that provides a complementary tool to other ways of assessing airway disease in asthma patients including spirometry and as part of the diagnostic algorithm for both children over 5 and adults with respiratory symptoms suggestive of asthma, but has also demonstrated utility for managing asthma and selecting therapies for this disease. A common question is “How do FeNO and spirometry complement each other and why do I need both?” 

During this webinar, our speaker Dr. Philip E Silkoff will try and answer this question by reviewing the current evidence on the relationship between FeNO & Spirometry and how these tools can be used together for the Asthmatic patients. 

Public cible

Respiratory Therapists, PFT Therapists, Quality Therapists


Appréciation générale

4.4 / 5


4.4 / 5


4.5 / 5

Connaissances acquises

4.2 / 5


4.4 / 5


Lindsay Z.

Excellent, thank you very much


Jessique K.


Krista T.

The sound was not always good. (I don't know if it was caused by my computer or by your system)


Monique W.


Kevin H.


Sarel v.